ArticleNature communications2025
Boosting the activity in the liquid-phase hydrogenation of S-containing nitroarenes by dual-site Pt/CeO
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Disordered vacancy-isolated Ce-Gd-O clusters achieve exceptional low-temperature oxygen-ion conductivity for fuel cells.Science advances · 2026Article
- Nanogalvanic cell catalysts: bridging electrochemical and thermal catalysis.National science review · 2026Article
- Dynamic Polaronic Control of Metal Cluster Adaptability on Reducible Oxides.Journal of the American Chemical Society · 2026Article
- Paramagnetic active sites boosted hydrogenation ofRSC advances · 2026Article
- Biocatalytic reduction of nitro-sulfonamides: enzyme engineering, process integration, and sustainable pathways toFrontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The liquid phase hydrogenation of nitroarenes is an important industrial reaction. The active sites are typically supported metal nanoparticles, which can be easily deactivated when sulfur groups are present in the substrate. Here, we report a new strategy for converting these S-containing nitroarenes by developing a dual-sites Pt/CeO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.